These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 22747829)
1. Predictors for visual dysfunction in nonfunctioning pituitary adenomas - implications for neurosurgical management. Schmalisch K; Milian M; Schimitzek T; Lagrèze WA; Honegger J Clin Endocrinol (Oxf); 2012 Nov; 77(5):728-34. PubMed ID: 22747829 [TBL] [Abstract][Full Text] [Related]
2. The Predictive Value of Suprasellar Extension for Visual Function Evaluation in Chinese Patients with Nonfunctioning Pituitary Adenoma with Optic Chiasm Compression. Gan L; Ma J; Feng F; Wang Y; Cui J; Guo X; Zhang X; You H; Wang Z; Yin Z; Zhong Y; Xing B World Neurosurg; 2018 Aug; 116():e960-e967. PubMed ID: 29857216 [TBL] [Abstract][Full Text] [Related]
3. Objective criteria for successful transsphenoidal removal of suprasellar nonfunctioning pituitary adenomas. A prospective study. Honegger J; Ernemann U; Psaras T; Will B Acta Neurochir (Wien); 2007 Jan; 149(1):21-9; discussion 29. PubMed ID: 17086476 [TBL] [Abstract][Full Text] [Related]
4. Visual field defects in patients with pituitary adenomas. Huang WC; Lee LS Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):245-51. PubMed ID: 9509679 [TBL] [Abstract][Full Text] [Related]
5. Intraoperative magnetic resonance imaging and early prognosis for vision after transsphenoidal surgery for sellar lesions. Berkmann S; Fandino J; Zosso S; Killer HE; Remonda L; Landolt H J Neurosurg; 2011 Sep; 115(3):518-27. PubMed ID: 21639700 [TBL] [Abstract][Full Text] [Related]
6. Prognostic factors for visual recovery after transsphenoidal pituitary adenectomy. Lee S; Kim SJ; Yu YS; Kim YH; Paek SH; Kim DG; Jung HW Br J Neurosurg; 2013 Aug; 27(4):425-9. PubMed ID: 23421587 [TBL] [Abstract][Full Text] [Related]
7. Clinical features associated with lesions other than pituitary adenoma in patients with an optic chiasmal syndrome. Mejico LJ; Miller NR; Dong LM Am J Ophthalmol; 2004 May; 137(5):908-13. PubMed ID: 15126157 [TBL] [Abstract][Full Text] [Related]
8. Cognitive function surrounding resection of nonfunctioning pituitary adenomas with suprasellar extension: A prospective matched-control study. Hendrix P; Griessenauer CJ; Hans E; Simgen A; Oertel J; Karbach J J Clin Neurosci; 2017 Jun; 40():109-114. PubMed ID: 28284581 [TBL] [Abstract][Full Text] [Related]
9. Suprasellar extension independently predicts preoperative pituitary hormone deficiencies in patients with nonfunctioning pituitary macroadenomas: a single-center experience. Margaritopoulos D; Vassiliadi DA; Markou M; Evangelatou E; Tzanela M; Tsagarakis S Hormones (Athens); 2020 Jun; 19(2):245-251. PubMed ID: 32124257 [TBL] [Abstract][Full Text] [Related]
10. The pattern of visual impairment in patients with pituitary adenoma. Wang H; Sun W; Fu Z; Si Z; Zhu Y; Zhai G; Zhao G; Xu S; Pang Q J Int Med Res; 2008; 36(5):1064-9. PubMed ID: 18831902 [TBL] [Abstract][Full Text] [Related]
11. [Surgical treatment for giant pituitary adenomas: the state of visual functions]. Kadashev BA; Faĭzullaev RB; Kalinin PL; Kutin MA; Shkarubo AN; Alekseev SN; Fomichev DV; Grigor'eva NN; Tropinskaia OF Vestn Oftalmol; 2009; 125(2):7-10. PubMed ID: 19517822 [TBL] [Abstract][Full Text] [Related]
13. Chiasma syndrome in acromegalic patients--correlation of neuroradiologic and neuroophthalmologic findings. Gnjidić Z; Iveković R; Rumboldt Z; Malenica M; Vizner B; Berković M Coll Antropol; 2002 Dec; 26(2):601-8. PubMed ID: 12528288 [TBL] [Abstract][Full Text] [Related]
14. Pattern visual evoked potentials represent an early index for the evolution of optic chiasma syndrome of tumoral etiology. Badiu C; Serbănescu A; Coculescu M Rom J Physiol; 1996; 33(1-4):91-100. PubMed ID: 9117342 [TBL] [Abstract][Full Text] [Related]
15. The suprasellar volume of nonfunctioning pituitary adenomas: a useful tool for predicting visual field deficits. Bonomo G; Bertani GA; Carrabba GG; Ferrante E; Pluderi M; Guastella C; Pignataro L; Rampini P; Mantovani G; Locatelli M Pituitary; 2020 Oct; 23(5):552-557. PubMed ID: 32562134 [TBL] [Abstract][Full Text] [Related]
16. [Transsphenoidal Microneurosurgery. Part 4: Neuroophthalmological cure in pituitary adenoma]. Oi S; Ciric IS No Shinkei Geka; 1982 Nov; 10(11):1183-7. PubMed ID: 7155292 [TBL] [Abstract][Full Text] [Related]
17. Predictive factors for the development of visual loss in patients with pituitary macroadenomas and for visual recovery after optic pathway decompression. Monteiro ML; Zambon BK; Cunha LP Can J Ophthalmol; 2010 Aug; 45(4):404-8. PubMed ID: 20648089 [TBL] [Abstract][Full Text] [Related]
18. Visual disturbances in patients with pituitary adenoma. Ikeda H; Yoshimoto T Acta Neurol Scand; 1995 Aug; 92(2):157-60. PubMed ID: 7484065 [TBL] [Abstract][Full Text] [Related]
19. [Visual acuity outcome and recurrence in large or huge pituitary adenomas operated with transcranial approach: comparison between frontotemporal and interhemispheric approaches]. Kurokawa Y; Uede T; Niwa J; Daibo M; Hashi K No Shinkei Geka; 1998 Sep; 26(9):813-21. PubMed ID: 9757458 [TBL] [Abstract][Full Text] [Related]
20. Predicting impairment of central vision from dimensions of the optic chiasm in patients with pituitary adenoma. Carrim ZI; Reeks GA; Chohan AW; Dunn LT; Hadley DM Acta Neurochir (Wien); 2007 Mar; 149(3):255-60; discussion 260. PubMed ID: 17273885 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]